EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity

Jingyang Li, Xiaoyu Han, Mayu Sun, Weida Li, Guanghuan Yang, Huiyi Chen, Bao Guo, Jingquan Li, Xiaoguang Li iD, Hui Wang iD

Journal for ImmunoTherapy of Cancer · 2023-12 · 11 (12) · e007625

DOI: 10.1136/jitc-2023-007625 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 06.12.2023. Verfasst von Jingyang Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of M…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Interferon Type I, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, Innovative research team of high-level local universities in Shanghai and Shanghai Jiao Tong University Key Program of Medical Engineering, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antineoplastic chemotherapies are dramatically efficient when they provoke immunogenic cell death (ICD), thus inducing an antitumor immune response and even tumor elimination. However, activated caspases, the hallmark of most cancer chemotherapeutic agents, render apoptosis immunologically silent. Whether they are dispensable for chemotherapy-induced cell death and the apoptotic clearance of cells in vivo is still elusive.

Methods

A rational cell-based anticancer drug library screening was performed to explore the immunogenic apoptosis pathway and therapeutic targets under apoptotic caspase inhibition. Based on this screening, the potential of caspase inhibition in enhancing chemotherapy-induced antitumor immunity and the mechanism of actions was investigated by various cells and mouse models.

Results

Heat shock protein 90 (Hsp90) inhibition activates caspases in tumor cells to produce abundant genomic and mitochondrial DNA fragments and results in cell apoptosis. Meanwhile, it hijacks Caspase-9 signaling to suppress intrinsic DNA sensing. Pharmacological blockade or genetic deletion of Caspase-9 causes tumor cells to secrete interferon (IFN)-β via tumor intrinsic mitochondrial DNA/the second messenger cyclic GMP–AMP (cGAS) /stimulator of interferon genes (STING) pathway without impairing Hsp90 inhibition-induced cell death. Importantly, both Caspase-9 and Hsp90 inhibition triggers an ICD, leading to the release of numerous damage-associated molecular patterns such as high-mobility group box protein 1, ATP and type I IFNs in vitro and remarkable antitumor effects in vivo. Moreover, the combination treatment also induces adaptive resistance by upregulating programmed death-ligand 1 (PD-L1). Additional PD-L1 blockade can further overcome this acquired immune resistance and achieve complete tumor regression.

Conclusions

Blockade of Caspase-9 signaling selectively provokes Hsp90-based chemotherapy-mediated tumor innate sensing, leading to CD8 + T cell-dependent tumor control. Our findings implicate that pharmacological modulation of caspase pathway increases the tumor-intrinsic innate sensing and immunogenicity of chemotherapy-induced apoptosis, and synergizes with immunotherapy to overcome adaptive resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsInterferon Type INeoplasmsAnimalsMiceB7-H1 AntigenCaspase 9CaspasesDNA, MitochondrialHSP90 Heat-Shock Proteins

Substanzen

Antineoplastic AgentsB7-H1 AntigenCaspase 9CaspasesDNA, MitochondrialHSP90 Heat-Shock ProteinsInterferon Type ICasp9 protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • State Key Laboratory of Systems Medicine for Cancer, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China lixg@shsmu.edu.cn huiwang@shsmu.edu.cn.

ORCID-Profile: Xiaoguang Li, Hui Wang

Förderung

  • National Key Research and Development Program of China
  • Innovative research team of high-level local universities in Shanghai and Shanghai Jiao Tong University Key Program of Medical Engineering
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality
  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Li, J., Han, X., Sun, M., Li, W., Yang, G., Chen, H., Guo, B., Li, J., Li, X., & Wang, H. (2023). Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity. Journal for ImmunoTherapy of Cancer, 11(12), e007625. https://doi.org/10.1136/jitc-2023-007625

Vancouver

Li J, Han X, Sun M, Li W, Yang G, Chen H, et al. Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity. Journal for ImmunoTherapy of Cancer. 2023;11(12):e007625. doi:10.1136/jitc-2023-007625

BibTeX
@article{Li2023,
  author = {Li, Jingyang and Han, Xiaoyu and Sun, Mayu and Li, Weida and Yang, Guanghuan and Chen, Huiyi and Guo, Bao and Li, Jingquan and Li, Xiaoguang and Wang, Hui},
  title = {Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2023},
  volume = {11},
  number = {12},
  pages = {e007625},
  doi = {10.1136/jitc-2023-007625}
}
Kostenlos starten →